Parallax Volatility Advisers, L.P. Corcept Therapeutics Inc Call Options Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2018 Feb 14, 2019	SELL	$11.29 - $17.19 $590,467 - $899,037	-52,300 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.27 - $15.65 $28,221 - $35,995	2,300 Added 4.6%	52,300 $733,000
Q1 2018 May 15, 2018	BUY	$14.59 - $25.5 $583,600 - $1.02 Million	40,000 Added 400.0%	50,000 $823,000
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $123,000 - $193,000	10,000	10,000 $193,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.55B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.